img

Global Tacrolimus Market Research Report 2024


Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Tacrolimus Market Research Report 2024

According to Mr Accuracy reports’s new survey, global Tacrolimus market is projected to reach US$ million in 2034, increasing from US$ million in 2024, with the CAGR of % during the period of 2023 to 2034. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Tacrolimus market research.
Key manufacturers engaged in the Tacrolimus industry include GSK, Abbott, Roche Pharma, Novartis, Mylan, Squibb, Astellas, Aarti Group and Takeda, etc. Among those manufacturers, the top 3 players guaranteed % supply worldwide in 2024.
When refers to consumption region, % volume of Tacrolimus were sold to North America, Europe and Asia Pacific in 2024. Moreover, China, plays a key role in the whole Tacrolimus market and estimated to attract more attentions from industry insiders and investors.
Report Scope
This report, based on historical analysis (2018-2024) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Tacrolimus market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.



By Company


GSK
Abbott
Roche Pharma
Novartis
Mylan
Squibb
Astellas
Aarti Group
Takeda
Huapont Pharma
Senju Pharmaceutical
Guike Pharmaceutical
Tecoland
Sandoz
ScinoPharm
RPG Life Science
Suzhou Pharmaceutical Technology
Accura Pharmaceuticals
Fujisawa Pharmaceutical
Sichuan Med-Shine Pharmaceutical
Sinopharm Chuankang Pharmaceutical
Yamanouchi Pharmaceutical
Zhongmei Huadong Pharmaceutical
Hisun Pharmaceutical
Segment by Type
Tacrolimus Capsules
Tacrolimus Ointment
Tacrolimus Injection

Segment by Application


Hospitals
Clinics
Other

Consumption by Region


North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
The Tacrolimus report covers below items
Chapter 1Product Basic Information (Definition, Type and Application)
Chapter 2Manufacturers’ Competition Patterns
Chapter 3Country Level Sales Analysis
Chapter 4Product Type Analysis
Chapter 5Product Application Analysis
Chapter 6Manufacturers’ Outline
Chapter 7Industry Chain, Market Channel and Customer Analysis
Chapter 8Market Opportunities and Challenges
Chapter 9Market Conclusions
Chapter 10Research Methodology and Data Source

Table of Content

1 Tacrolimus Market Overview
1.1 Product Overview and Scope of Tacrolimus
1.2 Tacrolimus Segment by Type
1.2.1 Global Tacrolimus Market Value Comparison by Type (2024-2034)
1.2.2 Tacrolimus Capsules
1.2.3 Tacrolimus Ointment
1.2.4 Tacrolimus Injection
1.3 Tacrolimus Segment by Application
1.3.1 Global Tacrolimus Market Value by Application: (2024-2034)
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Other
1.4 Global Tacrolimus Market Size Estimates and Forecasts
1.4.1 Global Tacrolimus Revenue 2018-2034
1.4.2 Global Tacrolimus Sales 2018-2034
1.4.3 Global Tacrolimus Market Average Price (2018-2034)
1.5 Assumptions and Limitations
2 Tacrolimus Market Competition by Manufacturers
2.1 Global Tacrolimus Sales Market Share by Manufacturers (2018-2023)
2.2 Global Tacrolimus Revenue Market Share by Manufacturers (2018-2023)
2.3 Global Tacrolimus Average Price by Manufacturers (2018-2023)
2.4 Global Tacrolimus Industry Ranking 2021 VS 2024 VS 2023
2.5 Global Key Manufacturers of Tacrolimus, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Tacrolimus, Product Type & Application
2.7 Tacrolimus Market Competitive Situation and Trends
2.7.1 Tacrolimus Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Tacrolimus Players Market Share by Revenue
2.7.3 Global Tacrolimus Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Tacrolimus Retrospective Market Scenario by Region
3.1 Global Tacrolimus Market Size by Region: 2018 Versus 2024 Versus 2034
3.2 Global Tacrolimus Global Tacrolimus Sales by Region: 2018-2034
3.2.1 Global Tacrolimus Sales by Region: 2018-2023
3.2.2 Global Tacrolimus Sales by Region: 2024-2034
3.3 Global Tacrolimus Global Tacrolimus Revenue by Region: 2018-2034
3.3.1 Global Tacrolimus Revenue by Region: 2018-2023
3.3.2 Global Tacrolimus Revenue by Region: 2024-2034
3.4 North America Tacrolimus Market Facts & Figures by Country
3.4.1 North America Tacrolimus Market Size by Country: 2018 VS 2024 VS 2034
3.4.2 North America Tacrolimus Sales by Country (2018-2034)
3.4.3 North America Tacrolimus Revenue by Country (2018-2034)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Tacrolimus Market Facts & Figures by Country
3.5.1 Europe Tacrolimus Market Size by Country: 2018 VS 2024 VS 2034
3.5.2 Europe Tacrolimus Sales by Country (2018-2034)
3.5.3 Europe Tacrolimus Revenue by Country (2018-2034)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Tacrolimus Market Facts & Figures by Country
3.6.1 Asia Pacific Tacrolimus Market Size by Country: 2018 VS 2024 VS 2034
3.6.2 Asia Pacific Tacrolimus Sales by Country (2018-2034)
3.6.3 Asia Pacific Tacrolimus Revenue by Country (2018-2034)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Tacrolimus Market Facts & Figures by Country
3.7.1 Latin America Tacrolimus Market Size by Country: 2018 VS 2024 VS 2034
3.7.2 Latin America Tacrolimus Sales by Country (2018-2034)
3.7.3 Latin America Tacrolimus Revenue by Country (2018-2034)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Tacrolimus Market Facts & Figures by Country
3.8.1 Middle East and Africa Tacrolimus Market Size by Country: 2018 VS 2024 VS 2034
3.8.2 Middle East and Africa Tacrolimus Sales by Country (2018-2034)
3.8.3 Middle East and Africa Tacrolimus Revenue by Country (2018-2034)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Tacrolimus Sales by Type (2018-2034)
4.1.1 Global Tacrolimus Sales by Type (2018-2023)
4.1.2 Global Tacrolimus Sales by Type (2024-2034)
4.1.3 Global Tacrolimus Sales Market Share by Type (2018-2034)
4.2 Global Tacrolimus Revenue by Type (2018-2034)
4.2.1 Global Tacrolimus Revenue by Type (2018-2023)
4.2.2 Global Tacrolimus Revenue by Type (2024-2034)
4.2.3 Global Tacrolimus Revenue Market Share by Type (2018-2034)
4.3 Global Tacrolimus Price by Type (2018-2034)
5 Segment by Application
5.1 Global Tacrolimus Sales by Application (2018-2034)
5.1.1 Global Tacrolimus Sales by Application (2018-2023)
5.1.2 Global Tacrolimus Sales by Application (2024-2034)
5.1.3 Global Tacrolimus Sales Market Share by Application (2018-2034)
5.2 Global Tacrolimus Revenue by Application (2018-2034)
5.2.1 Global Tacrolimus Revenue by Application (2018-2023)
5.2.2 Global Tacrolimus Revenue by Application (2024-2034)
5.2.3 Global Tacrolimus Revenue Market Share by Application (2018-2034)
5.3 Global Tacrolimus Price by Application (2018-2034)
6 Key Companies Profiled
6.1 GSK
6.1.1 GSK Corporation Information
6.1.2 GSK Description and Business Overview
6.1.3 GSK Tacrolimus Sales, Revenue and Gross Margin (2018-2023)
6.1.4 GSK Tacrolimus Product Portfolio
6.1.5 GSK Recent Developments/Updates
6.2 Abbott
6.2.1 Abbott Corporation Information
6.2.2 Abbott Description and Business Overview
6.2.3 Abbott Tacrolimus Sales, Revenue and Gross Margin (2018-2023)
6.2.4 Abbott Tacrolimus Product Portfolio
6.2.5 Abbott Recent Developments/Updates
6.3 Roche Pharma
6.3.1 Roche Pharma Corporation Information
6.3.2 Roche Pharma Description and Business Overview
6.3.3 Roche Pharma Tacrolimus Sales, Revenue and Gross Margin (2018-2023)
6.3.4 Roche Pharma Tacrolimus Product Portfolio
6.3.5 Roche Pharma Recent Developments/Updates
6.4 Novartis
6.4.1 Novartis Corporation Information
6.4.2 Novartis Description and Business Overview
6.4.3 Novartis Tacrolimus Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Novartis Tacrolimus Product Portfolio
6.4.5 Novartis Recent Developments/Updates
6.5 Mylan
6.5.1 Mylan Corporation Information
6.5.2 Mylan Description and Business Overview
6.5.3 Mylan Tacrolimus Sales, Revenue and Gross Margin (2018-2023)
6.5.4 Mylan Tacrolimus Product Portfolio
6.5.5 Mylan Recent Developments/Updates
6.6 Squibb
6.6.1 Squibb Corporation Information
6.6.2 Squibb Description and Business Overview
6.6.3 Squibb Tacrolimus Sales, Revenue and Gross Margin (2018-2023)
6.6.4 Squibb Tacrolimus Product Portfolio
6.6.5 Squibb Recent Developments/Updates
6.7 Astellas
6.6.1 Astellas Corporation Information
6.6.2 Astellas Description and Business Overview
6.6.3 Astellas Tacrolimus Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Astellas Tacrolimus Product Portfolio
6.7.5 Astellas Recent Developments/Updates
6.8 Aarti Group
6.8.1 Aarti Group Corporation Information
6.8.2 Aarti Group Description and Business Overview
6.8.3 Aarti Group Tacrolimus Sales, Revenue and Gross Margin (2018-2023)
6.8.4 Aarti Group Tacrolimus Product Portfolio
6.8.5 Aarti Group Recent Developments/Updates
6.9 Takeda
6.9.1 Takeda Corporation Information
6.9.2 Takeda Description and Business Overview
6.9.3 Takeda Tacrolimus Sales, Revenue and Gross Margin (2018-2023)
6.9.4 Takeda Tacrolimus Product Portfolio
6.9.5 Takeda Recent Developments/Updates
6.10 Huapont Pharma
6.10.1 Huapont Pharma Corporation Information
6.10.2 Huapont Pharma Description and Business Overview
6.10.3 Huapont Pharma Tacrolimus Sales, Revenue and Gross Margin (2018-2023)
6.10.4 Huapont Pharma Tacrolimus Product Portfolio
6.10.5 Huapont Pharma Recent Developments/Updates
6.11 Senju Pharmaceutical
6.11.1 Senju Pharmaceutical Corporation Information
6.11.2 Senju Pharmaceutical Tacrolimus Description and Business Overview
6.11.3 Senju Pharmaceutical Tacrolimus Sales, Revenue and Gross Margin (2018-2023)
6.11.4 Senju Pharmaceutical Tacrolimus Product Portfolio
6.11.5 Senju Pharmaceutical Recent Developments/Updates
6.12 Guike Pharmaceutical
6.12.1 Guike Pharmaceutical Corporation Information
6.12.2 Guike Pharmaceutical Tacrolimus Description and Business Overview
6.12.3 Guike Pharmaceutical Tacrolimus Sales, Revenue and Gross Margin (2018-2023)
6.12.4 Guike Pharmaceutical Tacrolimus Product Portfolio
6.12.5 Guike Pharmaceutical Recent Developments/Updates
6.13 Tecoland
6.13.1 Tecoland Corporation Information
6.13.2 Tecoland Tacrolimus Description and Business Overview
6.13.3 Tecoland Tacrolimus Sales, Revenue and Gross Margin (2018-2023)
6.13.4 Tecoland Tacrolimus Product Portfolio
6.13.5 Tecoland Recent Developments/Updates
6.14 Sandoz
6.14.1 Sandoz Corporation Information
6.14.2 Sandoz Tacrolimus Description and Business Overview
6.14.3 Sandoz Tacrolimus Sales, Revenue and Gross Margin (2018-2023)
6.14.4 Sandoz Tacrolimus Product Portfolio
6.14.5 Sandoz Recent Developments/Updates
6.15 ScinoPharm
6.15.1 ScinoPharm Corporation Information
6.15.2 ScinoPharm Tacrolimus Description and Business Overview
6.15.3 ScinoPharm Tacrolimus Sales, Revenue and Gross Margin (2018-2023)
6.15.4 ScinoPharm Tacrolimus Product Portfolio
6.15.5 ScinoPharm Recent Developments/Updates
6.16 RPG Life Science
6.16.1 RPG Life Science Corporation Information
6.16.2 RPG Life Science Tacrolimus Description and Business Overview
6.16.3 RPG Life Science Tacrolimus Sales, Revenue and Gross Margin (2018-2023)
6.16.4 RPG Life Science Tacrolimus Product Portfolio
6.16.5 RPG Life Science Recent Developments/Updates
6.17 Suzhou Pharmaceutical Technology
6.17.1 Suzhou Pharmaceutical Technology Corporation Information
6.17.2 Suzhou Pharmaceutical Technology Tacrolimus Description and Business Overview
6.17.3 Suzhou Pharmaceutical Technology Tacrolimus Sales, Revenue and Gross Margin (2018-2023)
6.17.4 Suzhou Pharmaceutical Technology Tacrolimus Product Portfolio
6.17.5 Suzhou Pharmaceutical Technology Recent Developments/Updates
6.18 Accura Pharmaceuticals
6.18.1 Accura Pharmaceuticals Corporation Information
6.18.2 Accura Pharmaceuticals Tacrolimus Description and Business Overview
6.18.3 Accura Pharmaceuticals Tacrolimus Sales, Revenue and Gross Margin (2018-2023)
6.18.4 Accura Pharmaceuticals Tacrolimus Product Portfolio
6.18.5 Accura Pharmaceuticals Recent Developments/Updates
6.19 Fujisawa Pharmaceutical
6.19.1 Fujisawa Pharmaceutical Corporation Information
6.19.2 Fujisawa Pharmaceutical Tacrolimus Description and Business Overview
6.19.3 Fujisawa Pharmaceutical Tacrolimus Sales, Revenue and Gross Margin (2018-2023)
6.19.4 Fujisawa Pharmaceutical Tacrolimus Product Portfolio
6.19.5 Fujisawa Pharmaceutical Recent Developments/Updates
6.20 Sichuan Med-Shine Pharmaceutical
6.20.1 Sichuan Med-Shine Pharmaceutical Corporation Information
6.20.2 Sichuan Med-Shine Pharmaceutical Tacrolimus Description and Business Overview
6.20.3 Sichuan Med-Shine Pharmaceutical Tacrolimus Sales, Revenue and Gross Margin (2018-2023)
6.20.4 Sichuan Med-Shine Pharmaceutical Tacrolimus Product Portfolio
6.20.5 Sichuan Med-Shine Pharmaceutical Recent Developments/Updates
6.21 Sinopharm Chuankang Pharmaceutical
6.21.1 Sinopharm Chuankang Pharmaceutical Corporation Information
6.21.2 Sinopharm Chuankang Pharmaceutical Tacrolimus Description and Business Overview
6.21.3 Sinopharm Chuankang Pharmaceutical Tacrolimus Sales, Revenue and Gross Margin (2018-2023)
6.21.4 Sinopharm Chuankang Pharmaceutical Tacrolimus Product Portfolio
6.21.5 Sinopharm Chuankang Pharmaceutical Recent Developments/Updates
6.22 Yamanouchi Pharmaceutical
6.22.1 Yamanouchi Pharmaceutical Corporation Information
6.22.2 Yamanouchi Pharmaceutical Tacrolimus Description and Business Overview
6.22.3 Yamanouchi Pharmaceutical Tacrolimus Sales, Revenue and Gross Margin (2018-2023)
6.22.4 Yamanouchi Pharmaceutical Tacrolimus Product Portfolio
6.22.5 Yamanouchi Pharmaceutical Recent Developments/Updates
6.23 Zhongmei Huadong Pharmaceutical
6.23.1 Zhongmei Huadong Pharmaceutical Corporation Information
6.23.2 Zhongmei Huadong Pharmaceutical Tacrolimus Description and Business Overview
6.23.3 Zhongmei Huadong Pharmaceutical Tacrolimus Sales, Revenue and Gross Margin (2018-2023)
6.23.4 Zhongmei Huadong Pharmaceutical Tacrolimus Product Portfolio
6.23.5 Zhongmei Huadong Pharmaceutical Recent Developments/Updates
6.24 Hisun Pharmaceutical
6.24.1 Hisun Pharmaceutical Corporation Information
6.24.2 Hisun Pharmaceutical Tacrolimus Description and Business Overview
6.24.3 Hisun Pharmaceutical Tacrolimus Sales, Revenue and Gross Margin (2018-2023)
6.24.4 Hisun Pharmaceutical Tacrolimus Product Portfolio
6.24.5 Hisun Pharmaceutical Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Tacrolimus Industry Chain Analysis
7.2 Tacrolimus Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Tacrolimus Production Mode & Process
7.4 Tacrolimus Sales and Marketing
7.4.1 Tacrolimus Sales Channels
7.4.2 Tacrolimus Distributors
7.5 Tacrolimus Customers
8 Tacrolimus Market Dynamics
8.1 Tacrolimus Industry Trends
8.2 Tacrolimus Market Drivers
8.3 Tacrolimus Market Challenges
8.4 Tacrolimus Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer

List of Figure

List of Tables
Table 1. Global Tacrolimus Market Value Comparison by Type (2024-2034) & (US$ Million)
Table 2. Global Tacrolimus Market Value Comparison by Application (2024-2034) & (US$ Million)
Table 3. Global Tacrolimus Market Competitive Situation by Manufacturers in 2024
Table 4. Global Tacrolimus Sales (K MT) of Key Manufacturers (2018-2023)
Table 5. Global Tacrolimus Sales Market Share by Manufacturers (2018-2023)
Table 6. Global Tacrolimus Revenue (US$ Million) by Manufacturers (2018-2023)
Table 7. Global Tacrolimus Revenue Share by Manufacturers (2018-2023)
Table 8. Global Market Tacrolimus Average Price (USD/MT) of Key Manufacturers (2018-2023)
Table 9. Global Key Players of Tacrolimus, Industry Ranking, 2021 VS 2024 VS 2023
Table 10. Global Key Manufacturers of Tacrolimus, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Tacrolimus, Product Type & Application
Table 12. Global Key Manufacturers of Tacrolimus, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Tacrolimus by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Tacrolimus as of 2024)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Tacrolimus Market Size by Region (US$ Million): 2018 VS 2024 VS 2034
Table 17. Global Tacrolimus Sales by Region (2018-2023) & (K MT)
Table 18. Global Tacrolimus Sales Market Share by Region (2018-2023)
Table 19. Global Tacrolimus Sales by Region (2024-2034) & (K MT)
Table 20. Global Tacrolimus Sales Market Share by Region (2024-2034)
Table 21. Global Tacrolimus Revenue by Region (2018-2023) & (US$ Million)
Table 22. Global Tacrolimus Revenue Market Share by Region (2018-2023)
Table 23. Global Tacrolimus Revenue by Region (2024-2034) & (US$ Million)
Table 24. Global Tacrolimus Revenue Market Share by Region (2024-2034)
Table 25. North America Tacrolimus Revenue by Country: 2018 VS 2024 VS 2034 (US$ Million)
Table 26. North America Tacrolimus Sales by Country (2018-2023) & (K MT)
Table 27. North America Tacrolimus Sales by Country (2024-2034) & (K MT)
Table 28. North America Tacrolimus Revenue by Country (2018-2023) & (US$ Million)
Table 29. North America Tacrolimus Revenue by Country (2024-2034) & (US$ Million)
Table 30. Europe Tacrolimus Revenue by Country: 2018 VS 2024 VS 2034 (US$ Million)
Table 31. Europe Tacrolimus Sales by Country (2018-2023) & (K MT)
Table 32. Europe Tacrolimus Sales by Country (2024-2034) & (K MT)
Table 33. Europe Tacrolimus Revenue by Country (2018-2023) & (US$ Million)
Table 34. Europe Tacrolimus Revenue by Country (2024-2034) & (US$ Million)
Table 35. Asia Pacific Tacrolimus Revenue by Region: 2018 VS 2024 VS 2034 (US$ Million)
Table 36. Asia Pacific Tacrolimus Sales by Region (2018-2023) & (K MT)
Table 37. Asia Pacific Tacrolimus Sales by Region (2024-2034) & (K MT)
Table 38. Asia Pacific Tacrolimus Revenue by Region (2018-2023) & (US$ Million)
Table 39. Asia Pacific Tacrolimus Revenue by Region (2024-2034) & (US$ Million)
Table 40. Latin America Tacrolimus Revenue by Country: 2018 VS 2024 VS 2034 (US$ Million)
Table 41. Latin America Tacrolimus Sales by Country (2018-2023) & (K MT)
Table 42. Latin America Tacrolimus Sales by Country (2024-2034) & (K MT)
Table 43. Latin America Tacrolimus Revenue by Country (2018-2023) & (US$ Million)
Table 44. Latin America Tacrolimus Revenue by Country (2024-2034) & (US$ Million)
Table 45. Middle East & Africa Tacrolimus Revenue by Country: 2018 VS 2024 VS 2034 (US$ Million)
Table 46. Middle East & Africa Tacrolimus Sales by Country (2018-2023) & (K MT)
Table 47. Middle East & Africa Tacrolimus Sales by Country (2024-2034) & (K MT)
Table 48. Middle East & Africa Tacrolimus Revenue by Country (2018-2023) & (US$ Million)
Table 49. Middle East & Africa Tacrolimus Revenue by Country (2024-2034) & (US$ Million)
Table 50. Global Tacrolimus Sales (K MT) by Type (2018-2023)
Table 51. Global Tacrolimus Sales (K MT) by Type (2024-2034)
Table 52. Global Tacrolimus Sales Market Share by Type (2018-2023)
Table 53. Global Tacrolimus Sales Market Share by Type (2024-2034)
Table 54. Global Tacrolimus Revenue (US$ Million) by Type (2018-2023)
Table 55. Global Tacrolimus Revenue (US$ Million) by Type (2024-2034)
Table 56. Global Tacrolimus Revenue Market Share by Type (2018-2023)
Table 57. Global Tacrolimus Revenue Market Share by Type (2024-2034)
Table 58. Global Tacrolimus Price (USD/MT) by Type (2018-2023)
Table 59. Global Tacrolimus Price (USD/MT) by Type (2024-2034)
Table 60. Global Tacrolimus Sales (K MT) by Application (2018-2023)
Table 61. Global Tacrolimus Sales (K MT) by Application (2024-2034)
Table 62. Global Tacrolimus Sales Market Share by Application (2018-2023)
Table 63. Global Tacrolimus Sales Market Share by Application (2024-2034)
Table 64. Global Tacrolimus Revenue (US$ Million) by Application (2018-2023)
Table 65. Global Tacrolimus Revenue (US$ Million) by Application (2024-2034)
Table 66. Global Tacrolimus Revenue Market Share by Application (2018-2023)
Table 67. Global Tacrolimus Revenue Market Share by Application (2024-2034)
Table 68. Global Tacrolimus Price (USD/MT) by Application (2018-2023)
Table 69. Global Tacrolimus Price (USD/MT) by Application (2024-2034)
Table 70. GSK Corporation Information
Table 71. GSK Description and Business Overview
Table 72. GSK Tacrolimus Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2018-2023)
Table 73. GSK Tacrolimus Product
Table 74. GSK Recent Developments/Updates
Table 75. Abbott Corporation Information
Table 76. Abbott Description and Business Overview
Table 77. Abbott Tacrolimus Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2018-2023)
Table 78. Abbott Tacrolimus Product
Table 79. Abbott Recent Developments/Updates
Table 80. Roche Pharma Corporation Information
Table 81. Roche Pharma Description and Business Overview
Table 82. Roche Pharma Tacrolimus Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2018-2023)
Table 83. Roche Pharma Tacrolimus Product
Table 84. Roche Pharma Recent Developments/Updates
Table 85. Novartis Corporation Information
Table 86. Novartis Description and Business Overview
Table 87. Novartis Tacrolimus Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2018-2023)
Table 88. Novartis Tacrolimus Product
Table 89. Novartis Recent Developments/Updates
Table 90. Mylan Corporation Information
Table 91. Mylan Description and Business Overview
Table 92. Mylan Tacrolimus Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2018-2023)
Table 93. Mylan Tacrolimus Product
Table 94. Mylan Recent Developments/Updates
Table 95. Squibb Corporation Information
Table 96. Squibb Description and Business Overview
Table 97. Squibb Tacrolimus Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2018-2023)
Table 98. Squibb Tacrolimus Product
Table 99. Squibb Recent Developments/Updates
Table 100. Astellas Corporation Information
Table 101. Astellas Description and Business Overview
Table 102. Astellas Tacrolimus Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2018-2023)
Table 103. Astellas Tacrolimus Product
Table 104. Astellas Recent Developments/Updates
Table 105. Aarti Group Corporation Information
Table 106. Aarti Group Description and Business Overview
Table 107. Aarti Group Tacrolimus Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2018-2023)
Table 108. Aarti Group Tacrolimus Product
Table 109. Aarti Group Recent Developments/Updates
Table 110. Takeda Corporation Information
Table 111. Takeda Description and Business Overview
Table 112. Takeda Tacrolimus Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2018-2023)
Table 113. Takeda Tacrolimus Product
Table 114. Takeda Recent Developments/Updates
Table 115. Huapont Pharma Corporation Information
Table 116. Huapont Pharma Description and Business Overview
Table 117. Huapont Pharma Tacrolimus Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2018-2023)
Table 118. Huapont Pharma Tacrolimus Product
Table 119. Huapont Pharma Recent Developments/Updates
Table 120. Senju Pharmaceutical Corporation Information
Table 121. Senju Pharmaceutical Description and Business Overview
Table 122. Senju Pharmaceutical Tacrolimus Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2018-2023)
Table 123. Senju Pharmaceutical Tacrolimus Product
Table 124. Senju Pharmaceutical Recent Developments/Updates
Table 125. Guike Pharmaceutical Corporation Information
Table 126. Guike Pharmaceutical Description and Business Overview
Table 127. Guike Pharmaceutical Tacrolimus Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2018-2023)
Table 128. Guike Pharmaceutical Tacrolimus Product
Table 129. Guike Pharmaceutical Recent Developments/Updates
Table 130. Tecoland Corporation Information
Table 131. Tecoland Description and Business Overview
Table 132. Tecoland Tacrolimus Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2018-2023)
Table 133. Tecoland Tacrolimus Product
Table 134. Tecoland Recent Developments/Updates
Table 135. Sandoz Corporation Information
Table 136. Sandoz Description and Business Overview
Table 137. Sandoz Tacrolimus Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2018-2023)
Table 138. Sandoz Tacrolimus Product
Table 139. Sandoz Recent Developments/Updates
Table 140. ScinoPharm Corporation Information
Table 141. ScinoPharm Description and Business Overview
Table 142. ScinoPharm Tacrolimus Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2018-2023)
Table 143. ScinoPharm Tacrolimus Product
Table 144. ScinoPharm Recent Developments/Updates
Table 145. RPG Life Science Corporation Information
Table 146. RPG Life Science Description and Business Overview
Table 147. RPG Life Science Tacrolimus Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2018-2023)
Table 148. RPG Life Science Tacrolimus Product
Table 149. RPG Life Science Recent Developments/Updates
Table 150. Suzhou Pharmaceutical Technology Corporation Information
Table 151. Suzhou Pharmaceutical Technology Description and Business Overview
Table 152. Suzhou Pharmaceutical Technology Tacrolimus Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2018-2023)
Table 153. Suzhou Pharmaceutical Technology Tacrolimus Product
Table 154. Suzhou Pharmaceutical Technology Recent Developments/Updates
Table 155. Accura Pharmaceuticals Corporation Information
Table 156. Accura Pharmaceuticals Description and Business Overview
Table 157. Accura Pharmaceuticals Tacrolimus Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2018-2023)
Table 158. Accura Pharmaceuticals Tacrolimus Product
Table 159. Accura Pharmaceuticals Recent Developments/Updates
Table 160. Fujisawa Pharmaceutical Corporation Information
Table 161. Fujisawa Pharmaceutical Description and Business Overview
Table 162. Fujisawa Pharmaceutical Tacrolimus Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2018-2023)
Table 163. Fujisawa Pharmaceutical Tacrolimus Product
Table 164. Fujisawa Pharmaceutical Recent Developments/Updates
Table 165. Sichuan Med-Shine Pharmaceutical Corporation Information
Table 166. Sichuan Med-Shine Pharmaceutical Description and Business Overview
Table 167. Sichuan Med-Shine Pharmaceutical Tacrolimus Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2018-2023)
Table 168. Sichuan Med-Shine Pharmaceutical Tacrolimus Product
Table 169. Sichuan Med-Shine Pharmaceutical Recent Developments/Updates
Table 170. Sinopharm Chuankang Pharmaceutical Corporation Information
Table 171. Sinopharm Chuankang Pharmaceutical Description and Business Overview
Table 172. Sinopharm Chuankang Pharmaceutical Tacrolimus Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2018-2023)
Table 173. Sinopharm Chuankang Pharmaceutical Tacrolimus Product
Table 174. Sinopharm Chuankang Pharmaceutical Recent Developments/Updates
Table 175. Yamanouchi Pharmaceutical Corporation Information
Table 176. Yamanouchi Pharmaceutical Description and Business Overview
Table 177. Yamanouchi Pharmaceutical Tacrolimus Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2018-2023)
Table 178. Yamanouchi Pharmaceutical Tacrolimus Product
Table 179. Yamanouchi Pharmaceutical Recent Developments/Updates
Table 180. Zhongmei Huadong Pharmaceutical Corporation Information
Table 181. Zhongmei Huadong Pharmaceutical Description and Business Overview
Table 182. Zhongmei Huadong Pharmaceutical Tacrolimus Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2018-2023)
Table 183. Zhongmei Huadong Pharmaceutical Tacrolimus Product
Table 184. Zhongmei Huadong Pharmaceutical Recent Developments/Updates
Table 185. Hisun Pharmaceutical Corporation Information
Table 186. Hisun Pharmaceutical Description and Business Overview
Table 187. Hisun Pharmaceutical Tacrolimus Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2018-2023)
Table 188. Hisun Pharmaceutical Tacrolimus Product
Table 189. Hisun Pharmaceutical Recent Developments/Updates
Table 190. Key Raw Materials Lists
Table 191. Raw Materials Key Suppliers Lists
Table 192. Tacrolimus Distributors List
Table 193. Tacrolimus Customers List
Table 194. Tacrolimus Market Trends
Table 195. Tacrolimus Market Drivers
Table 196. Tacrolimus Market Challenges
Table 197. Tacrolimus Market Restraints
Table 198. Research Programs/Design for This Report
Table 199. Key Data Information from Secondary Sources
Table 200. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Tacrolimus
Figure 2. Global Tacrolimus Market Value Comparison by Type (2024-2034) & (US$ Million)
Figure 3. Global Tacrolimus Market Share by Type in 2024 & 2034
Figure 4. Tacrolimus Capsules Product Picture
Figure 5. Tacrolimus Ointment Product Picture
Figure 6. Tacrolimus Injection Product Picture
Figure 7. Global Tacrolimus Market Value Comparison by Application (2024-2034) & (US$ Million)
Figure 8. Global Tacrolimus Market Share by Application in 2024 & 2034
Figure 9. Hospitals
Figure 10. Clinics
Figure 11. Other
Figure 12. Global Tacrolimus Revenue, (US$ Million), 2018 VS 2024 VS 2034
Figure 13. Global Tacrolimus Market Size (2018-2034) & (US$ Million)
Figure 14. Global Tacrolimus Sales (2018-2034) & (K MT)
Figure 15. Global Tacrolimus Average Price (USD/MT) & (2018-2034)
Figure 16. Tacrolimus Report Years Considered
Figure 17. Tacrolimus Sales Share by Manufacturers in 2024
Figure 18. Global Tacrolimus Revenue Share by Manufacturers in 2024
Figure 19. The Global 5 and 10 Largest Tacrolimus Players: Market Share by Revenue in 2024
Figure 20. Tacrolimus Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2018 VS 2024
Figure 21. Global Tacrolimus Market Size by Region (US$ Million): 2018 VS 2024 VS 2034
Figure 22. North America Tacrolimus Sales Market Share by Country (2018-2034)
Figure 23. North America Tacrolimus Revenue Market Share by Country (2018-2034)
Figure 24. U.S. Tacrolimus Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 25. Canada Tacrolimus Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 26. Europe Tacrolimus Sales Market Share by Country (2018-2034)
Figure 27. Europe Tacrolimus Revenue Market Share by Country (2018-2034)
Figure 28. Germany Tacrolimus Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 29. France Tacrolimus Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 30. U.K. Tacrolimus Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 31. Italy Tacrolimus Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 32. Russia Tacrolimus Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 33. Asia Pacific Tacrolimus Sales Market Share by Region (2018-2034)
Figure 34. Asia Pacific Tacrolimus Revenue Market Share by Region (2018-2034)
Figure 35. China Tacrolimus Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 36. Japan Tacrolimus Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 37. South Korea Tacrolimus Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 38. India Tacrolimus Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 39. Australia Tacrolimus Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 40. Taiwan Tacrolimus Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 41. Indonesia Tacrolimus Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 42. Thailand Tacrolimus Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 43. Malaysia Tacrolimus Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 44. Philippines Tacrolimus Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 45. Latin America Tacrolimus Sales Market Share by Country (2018-2034)
Figure 46. Latin America Tacrolimus Revenue Market Share by Country (2018-2034)
Figure 47. Mexico Tacrolimus Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 48. Brazil Tacrolimus Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 49. Argentina Tacrolimus Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 50. Middle East & Africa Tacrolimus Sales Market Share by Country (2018-2034)
Figure 51. Middle East & Africa Tacrolimus Revenue Market Share by Country (2018-2034)
Figure 52. Turkey Tacrolimus Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 53. Saudi Arabia Tacrolimus Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 54. UAE Tacrolimus Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 55. Global Sales Market Share of Tacrolimus by Type (2018-2034)
Figure 56. Global Revenue Market Share of Tacrolimus by Type (2018-2034)
Figure 57. Global Tacrolimus Price (USD/MT) by Type (2018-2034)
Figure 58. Global Sales Market Share of Tacrolimus by Application (2018-2034)
Figure 59. Global Revenue Market Share of Tacrolimus by Application (2018-2034)
Figure 60. Global Tacrolimus Price (USD/MT) by Application (2018-2034)
Figure 61. Tacrolimus Value Chain
Figure 62. Tacrolimus Production Process
Figure 63. Channels of Distribution (Direct Vs Distribution)
Figure 64. Distributors Profiles
Figure 65. Bottom-up and Top-down Approaches for This Report
Figure 66. Data Triangulation
Figure 67. Key Executives Interviewed